T2DM (Y6) Flashcards
What is the cause of blurred vision in diabetes mellitus?
Osmotic effects of glucose on the lens of the eye –> alter refraction and blur vision
Patient should NOT see optician until blood glucose normalised
What is the initial management of T2DM at diagnosis ?`
Advice on diet
Advice on physcial activity
Screening for diabetic complications
Why is metformin 1st line? What needs to be monitored on it?
Good glucose lowering efficacy and is weight neutral
Increase dose gradually to avoid adverse effects
If intolerable switch to modified release metformin
RENAL function must be monitored BEFORE and DURING use
Which T2DM treatments increase weight?
Pioglitazone (thiazolidinediones - increases sensitivity)
Gliclazide (sulfonylurea - stimulates beta cells)
When are patients at increased risk of lactic acidosis with metformin?
If they are in renal failure
Which T2DM drug has a side effect of fluid retention?
thiazolidinediones (glitazones) - can sometimes precipitate cardiac failure
What are the main SE of metformin?
nausea and diarrhoea
lactic acidosis (rare)
Which T2DM drug causes hypoglycaemia?
Sulfonylureas
Insulin
In addition to the previously mentioned therapies what else needs to be considered in T2DM?
Cardiovascular risk factors = consider HTN and lipid therapies
1st line HTN = ACEi e.g. ramipril
Irrespective of the lipid profile however, this patient requires lipid-lowering therapy as most authorities recommend starting statin therapy in all diabetic patients aged 84 years and younger with a QRISK2 score of 10% or more.
What do statins reduce?
LDL
Summarise the medications used for T2DM, their side effects and effects on weight and hypoglycaemia.
Summarise the algorithm for first line treatments in T2DM.
Summarise the treatment options in T2DM if further interventions are needed after first line therapy.
List the 4 complications of microvascular disease in diabetes.
Renal damage
Retinopathy
Neuropathy - autonomic and peripheral
How often do you get screening for complications in type 2 diabetes?
Eye screening - at diagnosis and every 2 years if low risk (no previous retinopathy) or annually if high risk (previous retinopathy)
Foot check - at diagnosis then annually
Diabetic kidney disease - annually
Cardiovascular risk - BP, full lipid profile, height weight BMI = annually
Peripheral and autonomic neuropathy - varies